Lexicon Pharms Inc Drug Patent Portfolio
Lexicon Pharms Inc owns 1 orange book drug protected by 3 US patents Given below is the list of Lexicon Pharms Inc's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8217156 | Solid forms of (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol and methods of their use | 07 Oct, 2030 | Active |
| US8476413 | Sulfanyl-tetrahydropyran-based compounds and methods of their use | 29 May, 2028 | Active |
| US7781577 | Inhibitors of sodium glucose co-transporter 2 and methods of their use | 04 May, 2028 | Active |
Latest Legal Activities on Lexicon Pharms Inc's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Lexicon Pharms Inc.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Second letter to regulating agency to determine regulatory review period | 07 Feb, 2024 | US7781577 |
| Second letter to regulating agency to determine regulatory review period | 07 Feb, 2024 | US8217156 |
| Letter from FDA or Dept of Agriculture re PTE application | 30 Jan, 2024 | US8217156 |
| Letter from FDA or Dept of Agriculture re PTE application | 30 Jan, 2024 | US7781577 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 10 Jan, 2024 | US8217156 |
| Initial letter Re: PTE Application to regulating agency | 08 Aug, 2023 | US7781577 |
| Initial letter Re: PTE Application to regulating agency | 08 Aug, 2023 | US8217156 |
|
Electronic Review
Critical
| 25 Jul, 2023 | US8217156 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 25 Jul, 2023 | US8217156 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 25 Jul, 2023 | US7781577 |
|
Email Notification
Critical
| 25 Jul, 2023 | US7781577 |
|
Email Notification
Critical
| 25 Jul, 2023 | US8217156 |
|
Electronic Review
Critical
| 25 Jul, 2023 | US7781577 |
| Post Issue Communication - Certificate of Correction | 21 Jul, 2023 | US8217156 |
| Patent Term Extension Application under 35 USC 156 Filed | 20 Jul, 2023 | US8217156 |
Lexicon Pharms Inc's Family Patents
Lexicon Pharms Inc Drug List
Given below is the complete list of Lexicon Pharms Inc's drugs and the patents protecting them.
1. Inpefa
Inpefa is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8217156 | Solid forms of (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol and methods of their use |
07 Oct, 2030
(5 years from now)
| Active |
| US8476413 | Sulfanyl-tetrahydropyran-based compounds and methods of their use |
29 May, 2028
(3 years from now)
| Active |
| US7781577 | Inhibitors of sodium glucose co-transporter 2 and methods of their use |
04 May, 2028
(3 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Inpefa's drug page